ISRG241206C495000
- 0.00
- 0.000.00%
Intuitive Surgical Newsroom
Stifel Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $610
Intuitive Surgical Analyst Ratings
Stifel Adjusts Price Target on Intuitive Surgical to $610 From $525, Keeps Buy Rating
Morgan Stanley Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $650
Intuitive Surgical (ISRG) Gets a Buy From Leerink Partners
Intuitive Surgical Is Maintained at Buy by BTIG
Intuitive Surgical Analyst Ratings
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $561
BTIG Adjusts Price Target on Intuitive Surgical to $561 From $535, Maintains Buy Rating
Intuitive Surgical Analyst Ratings
Erste Group Initiates Intuitive Surgical(ISRG.US) With Buy Rating
HSBC Raises Intuitive Surgical Price Target to $643 From $586
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating
Intuitive Surgical (ISRG) Gets a Buy From Bank of America Securities
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
Argus Adjusts Price Target on Intuitive Surgical to $570 From $520
Morgan Stanley Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $522
Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Amylyx Pharmaceuticals Inc (AMLX) and Intuitive Surgical (ISRG)
Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Mizuho Securities Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $550